Oxlumo®
OXLUMO® is a prescription medicine for the treatment of primary hyperoxaluria type 1 (PH1) to lower oxalate in urine and blood.
For more information, visit the patient website for this drug. Speak with your healthcare provider to learn if this drug is right for you.
MANUFACTURER: Alnylam Pharmaceuticals, Inc. |
CLASS: Gene Therapy |
WHAT IT TREATS: Primary Hyperoxaluria Type 1 |
PRESCRIBED BY: Nephrologists
|
HOW ADMINISTERED: Subcutaneous Injection |
FREQUENCY: Monthly |
Length of infusion: N/A |
FOR MORE INFORMATION: |
